User profiles for Arnaud Marchant

Arnaud Marchant

Université Libre de Bruxelles
Verified email at ulb.ac.be
Cited by 16971

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

C Gerard, C Bruyns, A Marchant… - The Journal of …, 1993 - rupress.org
Because of its ability to efficiently inhibit in vitro cytokine production by activated macrophages,
we hypothesized that interleukin (IL) 10 might be of particular interest in preventing …

Uninfected but not unaffected: chronic maternal infections during pregnancy, fetal immunity, and susceptibility to postnatal infections

…, TR Kollmann, J Levy, A Marchant - The Lancet infectious …, 2012 - thelancet.com
Chronic infections during pregnancy are highly prevalent in some parts of the world.
Infections with helminths, Trypanosoma cruzi, Plasmodium spp, and HIV might affect the …

[HTML][HTML] Mature CD8+ T lymphocyte response to viral infection during fetal life

A Marchant, V Appay, M Van Der Sande… - The Journal of …, 2003 - Am Soc Clin Investig
Immunization of newborns against viral infections may be hampered by ineffective CD8 + T
cell responses. To characterize the function of CD8 + T lymphocytes in early life, we studied …

[HTML][HTML] Immunological mechanisms of vaccine-induced protection against COVID-19 in humans

M Sadarangani, A Marchant… - Nature Reviews …, 2021 - nature.com
Most COVID-19 vaccines are designed to elicit immune responses, ideally neutralizing
antibodies (NAbs), against the SARS-CoV-2 spike protein. Several vaccines, including mRNA, …

Interleukin-10 production during septicaemia.

A Marchant, J Devière, B Byl, D De Groote… - Lancet (London …, 1994 - europepmc.org
Interleukin-10 is produced during incubation of human whole blood with bacterial
lipopolysaccharide (LPS) and down-regulates tumour necrosis factor-alpha production in this in-vitro …

[HTML][HTML] Immune Activation and CD8+ T-Cell Differentiation towards Senescence in HIV-1 Infection

L Papagno, CA Spina, A Marchant, M Salio… - PLoS …, 2004 - journals.plos.org
Progress in the fight against the HIV/AIDS epidemic is hindered by our failure to elucidate the
precise reasons for the onset of immunodeficiency in HIV-1 infection. Increasing evidence …

Newborns develop a Th1-type immune response to Mycobacterium bovis bacillus Calmette-Guerin vaccination

A Marchant, T Goetghebuer, MO Ota… - The Journal of …, 1999 - journals.aai.org
Data obtained in animals indicate that neonatal immune responses are biased toward Th2.
This could reduce the efficacy of vaccines against viral and mycobacterial diseases. The …

[PDF][PDF] Protecting the newborn and young infant from infectious diseases: lessons from immune ontogeny

…, B Kampmann, SK Mazmanian, A Marchant… - Immunity, 2017 - cell.com
Infections in the first year of life are common and often severe. The newborn host demonstrates
both quantitative and qualitative differences to the adult in nearly all aspects of immunity, …

Interleukin‐10 inhibits B7 and intercellular adhesion molecule‐1 expression on human monocytes

F Willems, A Marchant, JP Delville… - European journal of …, 1994 - Wiley Online Library
There is evidence that interleukin −10(IL‐10) interferes with the costimulatory properties of
antigen‐presenting cells and, thereby, inhibits their ability to induce T cell activation. To …

Prevalence and 6‐month recovery of olfactory dysfunction: a multicentre study of 1363 COVID‐19 patients

…, M Ducarme, F Journe, A Marchant… - Journal of internal …, 2021 - Wiley Online Library
Objective To investigate prevalence and recovery of olfactory dysfunction (OD) in COVID‐19
patients according to the disease severity. Methods From 22 March to 3 June 2020, 2581 …